Activation of STAT3/5 signal pathways in complete mole and repression in choriocarcinoma cell lines

Hidenori Kato1, Takafumi Inoue, Kazuo Asanoma

  • 1Division of Molecular and Cell Therapeutics, Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Tsurumihara 4546, Beppu City, Oita 874-0838, Japan. hidekato@beppu.kyushu-u.ac.jp

Abstract

Insights

Signal transducer and activator of transcription (STAT) signaling and survivin are upregulated in complete mole (CM). However, choriocarcinoma (CC) cells maintain survivin expression via MEK signaling, independent of STAT activation.

Area of Science:

  • Molecular biology
  • Signal transduction pathways
  • Trophoblastic diseases

Background:

  • Previous microarray studies suggested STAT5 and survivin upregulation in complete mole (CM).
  • The role of STAT-mediated signal transduction in CM and choriocarcinoma (CC) requires clarification.

Purpose of the Study:

  • To investigate the status of STAT-mediated signal transduction in CM and CC.
  • To determine the role of STAT and MEK signaling pathways in survivin expression in these conditions.

Main Methods:

  • Western blot (WB) analysis of STAT3 and STAT5 activation in CM, normal villi, and CC cell lines.
  • Inhibition of STAT and MEK pathways to assess changes in survivin expression.
  • Immunohistochemical staining of CM and normal villi for pSTATs.

Main Results:

  • Phosphorylated STAT3 and 5 (active forms) and survivin were significantly upregulated in CM compared to normal villi.
  • Immunohistochemistry revealed pSTAT signals in CM trophoblast layers, absent in normal villi.
  • CC cells showed minimal pSTAT detection by WB but maintained high survivin expression via MEK pathway activation.

Conclusions:

  • Activated STAT signaling likely contributes to the hyperplastic growth of trophoblasts in CM.
  • CC cells may achieve tumor growth independently of cytokine-driven STAT signals during carcinogenesis.
  • MEK pathway activation is crucial for survivin expression in CC, suggesting alternative oncogenic mechanisms.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...